Haloperidol
Haloperidol is a generic antipsychotic medication used to manage symptoms of schizophrenia, bipolar disorder, and other mental health conditions. It comes as oral tablets in strengths of 0.5mg, 1mg, 2mg, 5mg, 10mg, and 20mg, manufactured by Lifestar Pharma LLC under ANDA216918. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Haloperidol is a generic antipsychotic medication used to manage symptoms of schizophrenia, bipolar disorder, and other mental health conditions. It comes as oral tablets in strengths of 0.5mg, 1mg, 2mg, 5mg, 10mg, and 20mg, manufactured by Lifestar Pharma LLC under ANDA216918. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Haloperidol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Haloperidol — ANDA 211061 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211061"
}
]
|
| identifier | ANDA211061 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"health-care",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Haloperidol |
